Neuralstem, Inc.
(NASDAQ : CUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.31%198.001.2%$508.85m
GILDGilead Sciences, Inc.
0.10%73.660.9%$447.48m
BIIBBiogen Inc.
-0.07%330.711.3%$368.34m
CELGCelgene Corporation
0.10%82.661.2%$330.77m
ILMNIllumina, Inc.
-1.24%317.703.5%$286.85m
REGNRegeneron Pharmaceuticals, Inc.
-1.40%378.782.6%$220.81m
ALXNAlexion Pharmaceuticals, Inc.
0.74%122.842.0%$210.28m
VRTXVertex Pharmaceuticals Incorporated
-0.63%180.181.9%$202.20m
SRPTSarepta Therapeutics, Inc.
1.46%132.4116.4%$168.86m
AAgilent Technologies, Inc.
0.02%66.251.5%$154.57m
BMRNBioMarin Pharmaceutical Inc.
0.83%100.344.4%$129.42m
VKTXViking Therapeutics, Inc.
-1.59%14.230.9%$107.03m
LGNDLigand Pharmaceuticals Incorporated
-1.64%199.2723.3%$106.37m
NKTRNektar Therapeutics
0.41%49.115.6%$105.90m
EXASExact Sciences Corporation
-1.70%66.0825.3%$96.47m

Company Profile

Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.